| Financial Year |
March 31 2023 |
| Monetary Funds |
244,573,383.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
450,315,321.98 |
| Advances to Suppliers |
9,103,956.05 |
| Other Receivables |
5,498,003.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
80,043,514.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
948,347.84 |
| Total Current Assets |
792,373,320.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
617,293.14 |
| Investment Properties |
6,534,117.61 |
| Fixed Assetes |
2,718,860,126.49 |
| Under-construction Projects |
6,599,598.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,809,345,243.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
8,382,796.26 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
6,091,075,693.84 |
| Total Assets |
6,883,449,014.13 |
| Short-Term Loans |
220,211,138.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
188,768,930.37 |
| Accounts Received In Advance |
370,367.24 |
| Employee Compensation Payable |
39,972,847.87 |
| Taxes Payable |
10,379,690.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,459,541.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
213,389,890.13 |
| Other Current Liabilities |
729,929.81 |
| Sub-Total of Current Liabilities |
724,730,137.22 |
| Long-term Loans |
982,581,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,570,561.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,053,214,855.75 |
| Total Liabilities |
1,777,944,992.97 |
| Paid-In Capital(Or Share Stock) |
1,206,534,201.00 |
| Capital Surplus |
1,187,410,230.74 |
| Surplus Reserve |
302,405,444.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,202,625,409.61 |
| Minority Stockholder's Interest |
1,206,642,604.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,898,861,416.78 |
| Owner's Equity（Stockholder's Equity） |
5,105,504,021.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,883,449,014.13 |
